PMCQ Logo
English|Carte du Site
Dossiers spéciauxDernière mise à jour : 8 octobre 2019

Demandez au CCPP

Faire une recherche
Chercher par # de question

Afin de soutenir la demande croissante, nous avons modifé la section Demandez au CCPP et l'avons rendu plus facile d'utilisation. Vous pouvez désormais sélectioner la catégorie qui vous interesse dans le menu déroulant et voir les questions qui ont déjà été posées et répondues. Vous pouvez également faire une recherche parmis les questions déjà soumises au CCPP depuis les débuts.

Questions et réponses les plus récentes
107
For a launch product is the review time the same as an old product line. When a pharmaceutical submits to PAAB the promotional pieces needed at NoC does PAAB take their 10 full days for review or is it possible to take half of the time because it is a product in launch mode.
  • Voir réponse [+]
106

If the US indication is the same as the Canadian one, but the US Product Monograph is more comprehensive can it be cited instead?

  • Voir réponse [+]
105

Je travaille pour une agence de publicité et nous devons préparer un lancement de produit pour un produit pharmaceutique en vente libre, sous restriction, behind the counter (annexe II).

J'aimerais svp avoir les réglèments publicitaires à respecter pour chacune des provinces.

  • Voir réponse [+]
104

If a disease education piece is being submitted (pre-NOC) that contains no branding and no mention of drug or treatment, would a review paper be an acceptable reference?

  • Voir réponse [+]
103

If we have a non-branded poster, talking about a disease and with a call to action: talk to your doctor. This poster will be given to the secretary of the doctor's office by the pharmaceutical representative and then will be posted in the examining room. Is this subject to PAAB review?

Also with the poster there will be a booklet disease oriented for patients also to be given to secretary to be left in the examining room. Is this subject to PAAB review?

With that poster there will be a card to be given to the patient by the doctor with the same message and a call to action (talk to your doctor) is this also subject to PAAB review?

  • Voir réponse [+]
102

Can a pharmaceutical company provide ,upon request from a Third party HCP controlled website, a company produced educational slide deck ( disease and treatment) that has not been reviewed and approved by PAAB.

The third party website wishes to provide these educational slide kits to their members as self learning resources.

  • Voir réponse [+]
101

Can you please clarify the relationship between the placement of balancing information and a product logo?

It is unclear as to why the product logo must signify the 'end' of the main advertising message.

  • Voir réponse [+]
100

Are all promotional materials for health care professionals for natural health products required to have PAAB approval? or is this a voluntary action?

  • Voir réponse [+]
99

Does PAAB have specific rules regarding Pre-NOC communications

Are you allowed to send out a pre-NOC communication that focuses on the disease, patients current unmet need and that a new option for treatment is coming soon?

  • Voir réponse [+]
98
Do you have an example of how to write an APS? What I am allowed to exclude from the PI?
  • Voir réponse [+]
Commissaire adjoint  

Jennifer Carroll
Réviseur principal en communications

Pour visionner le
Code d’agrément de la publicité du CCPP
cliquez ici
Le Conseil Consultatif de
Publicité Pharmaceutique
Conférences à venir

Passez un bel été et on se verra en Septembre.